Tracked deals
183
183 tracked deals across 2015-2026.
Tracked deals
183
183 tracked deals across 2015-2026.
Buyer mix
Mixed buyer set
149 strategic · 104 pe
Top trend
Volume peaked in 2022
33 tracked deals announced in 2022.
Primary Insight
| Recurring buyer type (examples) | Where they show up | What they’re adding |
|---|---|---|
| Service and platform operators | Enrollment, transportation, wellness | Service delivery workflows and capacity |
| Diagnostics / research enablement | Oncology MRD surveillance; regulatory writing | Testing platforms and development support |
| Large pharma | Immunology/rare disease expansion | Commercial products and pipeline fit |
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| InTandem Capital Partners | 3 | Healthcare-services-focused private equity firm investing... | PE |
| Arsenal Capital Partners | 2 | Private equity firm specializing in middle-market industr... | PE |
| Ascend Learning | 2 | Healthcare and learning technology company offering testi... | Strategic |
| Coastal Medical Transportation Systems (CMTS) | 2 | Privately owned non-emergency medical transportation prov... | Strategic |
| GHO Capital Partners LLP | 2 | European specialist investor focused on healthcare growth... | PE |
| Health Enterprise Partners | 2 | Healthcare-focused private equity firm providing expansio... | PE |
| InTandem Capital Partners, LLC | 2 | Healthcare-services-focused private equity firm that inve... | PE |
| Insight Partners | 2 | Global software investor that provides growth capital and... | PE |
| Labcorp | 2 | Leading global life sciences company providing diagnostic... | Strategic |
| Laser MD Medspa | 2 | Operator of a multi-location medical spa chain offering l... | Strategic (PE-backed) |
Last 9 years
Supporting Data
Azara Healthcare acquired Advocatia, a digital-first public benefits enrollment platform, to help safety-net providers and health plans maintain Medicaid coverage during redetermination. The combined solution pairs Azara’s population health and risk stratification (DRVS) with Advocatia’s guided enrollment workflow for applications, documentation, and initial enrollment/renewal in 75 languages. Terms were not disclosed, and the platform was described as available immediately to Azara clients.
Coastal Medical Transportation Systems (CMTS) acquired Alert Ambulance Service as part of its continued regional expansion across New England. The deal is intended to strengthen both emergency and non-emergency medical transportation capacity and reduce care delivery gaps by integrating Alert’s routes and workforce into CMTS’s existing network.
Collegium Pharmaceutical, Inc. completed its acquisition of AZSTARYS, a prescription CNS stimulant for ADHD, from Corium Therapeutics. The deal is valued at approximately $650 million in cash, with additional milestone-based consideration of up to $135 million.
Cloudstate, a health and wellness platform for girls and young women, announced its acquisition of Girlhood, a community-driven Gen Z connection platform. The deal combines Cloudstate’s physical and emotional health expertise with Girlhood’s peer community and content ecosystem to create an “emotional safety and belonging” focused platform.
Baystate Health and Trinity Health of New England have signed a definitive agreement to transition Mercy Medical Center (and certain related Massachusetts JV affiliates and medical group entities) to Baystate Health, subject to regulatory approvals. The move is intended to strengthen local access to care in Western Massachusetts and improve the long-term sustainability of Mercy’s services.
CareDx, Inc. entered into a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million in upfront cash plus up to $100 million in revenue-based milestones. The transaction is expected to close in the third quarter of 2026 and expands CareDx’s precision medicine testing services into HPV-driven cancer MRD surveillance using Naveris’ TTMV DNA (NavDx) liquid biopsy platform.
Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.
Obsidian Therapeutics and Galera Therapeutics entered into a definitive all-stock merger agreement in which both companies will become wholly owned subsidiaries of a newly formed company. The combined company is expected to operate as Obsidian Therapeutics, Inc. and apply to list on Nasdaq under ticker OBX, supported by a $350 million concurrent private placement.
Flow Capital Corp. announced a US$1.75 million follow-on investment commitment in MiniLuxe Holding Corp., including a first tranche advance of US$1.35 million. The additional capital—if fully drawn—would bring Flow Capital’s total aggregate investment in MiniLuxe to US$7.925 million across four deployments, supporting studio growth and expansion via franchising, joint ventures, and acquisitions.
Biogen entered into a definitive agreement to acquire Apellis Pharmaceuticals in a ~$5.6 billion cash deal ($41 per share) that also includes contingent value rights (CVRs) tied to SYFOVRE sales performance. The transaction closed in May 2026 and made Apellis a wholly owned subsidiary of Biogen, adding commercial products EMPAVELI and SYFOVRE to Biogen’s immunology/rare disease portfolio and strengthening its expansion into nephrology.
Cambridge Innovation Institute (CII) announced it has acquired Neurotech Reports, a neurotechnology publication and conference series. CII said the deal expands its healthcare portfolio within its Cambridge VIP division, with the first joint event being the Bioelectronic Medicine Forum on April 14 in New York City.
Waters Corporation completed its previously announced combination of BD’s Biosciences and Diagnostic Solutions business with a wholly owned Waters subsidiary, creating a global life sciences and diagnostics leader focused on high-volume testing in regulated applications. BD spun off the business and received Waters equity, with BD receiving $4 billion in cash in connection with the transaction.
Konovo, a technology-first healthcare intelligence company, announced it has acquired Rare Patient Voice (RPV), a patient recruitment company with 200,000+ registered patients and family caregivers. The acquisition combines RPV’s patient community and recruitment expertise with Konovo’s intelligent platform and global HCP access to help researchers engage both patients and healthcare providers with speed and reliability.
Harmony Healthcare IT, a Novacap portfolio company based in South Bend, Indiana, has acquired Blue Elm, a MEDITECH data solutions provider headquartered in Natick, Massachusetts. The add-on expands Harmony's MEDITECH EHR data extraction, migration, optimization and archiving capabilities, consolidating a single partner for hospitals' MEDITECH data lifecycle.
BGB Group has acquired Hayden Consulting Group to expand its market access and patient services capabilities within its Strategic Advisory practice. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, and financial terms were not disclosed.
Element Solutions Inc. has completed its previously announced acquisition of EFC Gases & Advanced Materials (EFC) for approximately 12x forecasted 2026 adjusted EBITDA in cash. EFC will operate as a standalone business unit within Element Solutions’ newly renamed “Specialties Segment,” expanding capabilities in specialty and rare gases, advanced materials, and semiconductor- and space-related growth vectors.
SHINE Technologies completed its acquisition of Lantheus’ SPECT business, including the North Billerica, Massachusetts manufacturing facility and the diagnostic radiopharmaceutical product portfolio. The deal expands SHINE’s nuclear medicine platform with established SPECT production expertise and market relationships, positioning SHINE to strengthen the medical isotope supply chain for diagnostic imaging.
HBox, a virtual care platform for specialty practices, received a growth investment from Charlesbank’s Technology Opportunities Fund II to accelerate expansion of its virtual care capabilities and scale its remote monitoring and patient-engagement offerings. The transaction closed on December 17, 2025 and will support HBox’s efforts to broaden specialty coverage (cardiology, pulmonology, nephrology) and strengthen its position as a virtual clinic partner for independent specialty practices.
InTandem Capital Partners completed an equity investment in The Phia Group, a Canton, Massachusetts-based leader in healthcare cost containment. HarbourVest Partners and Partners Capital joined as co-investors, while WestView Capital Partners remains a significant existing investor; advisors to the transaction included Houlihan Lokey and TripleTree.
Innovative Lab Services (ILS) has acquired Overbrook Scientific, a provider of laboratory relocations, asset management, and multi-vendor instrument maintenance, to expand ILS's national footprint and specialized lifecycle capabilities. Overbrook's founder Ted Palashis and the full Overbrook team will join ILS and continue to lead laboratory lifecycle and technical services within the combined organization.
Activated Insights, a Cressey & Company–backed workforce enablement platform, has acquired CareAcademy to create an expanded workforce development and compliance training offering for long-term and post-acute care providers. The combined organization will integrate CareAcademy's training and compliance automation with Activated Insights' analytics, benchmarking, recruiting tools and interoperability to deliver a unified platform for home care, home health, hospice, assisted living and skilled nursing providers.
Cogir Real Estate has acquired the management platform of Epoch Senior Living, adding 16 senior living communities across Massachusetts, Connecticut, New York and New Hampshire. The Epoch team will remain in place, bringing over 1,300 employees and creating a new U.S. platform for Cogir to expand its presence in the Northeastern United States.
MD Esthetics, a New Harbor Capital portfolio company, has completed the acquisition of Joli Medical Spa, a Marshfield, Massachusetts-based medical spa founded by Kristen MacNeil. The transaction is an add-on that expands MD Esthetics' geographic footprint across the Boston and Cape Cod markets and brings Joli's seven licensed injectors and aestheticians onto the MD Esthetics platform.
Arlington Capital Partners completed a majority growth investment in Concord Biomedical Sciences and Emerging Technologies, Inc. (CBSET), a Boston-area provider of translational research and product development services for the medical device and life sciences markets. The investment is intended to help CBSET scale its integrated preclinical research and testing platform via capacity expansion and strategic add-on acquisitions.
Keensight Capital has agreed to acquire a majority stake in regenerative MedTech company Isto Biologics. Thompson Street Capital Partners (TSCP) will retain a minority stake alongside Isto’s management team.
Ascend Learning has acquired Laudio, an AI-enhanced frontline leader operations platform, to expand its healthcare workforce management and leadership capabilities. The acquisition integrates Laudio’s leader operations tools into Ascend’s learning and workforce solutions to better support frontline managers and improve employee engagement and patient experience.
PurpleLab has acquired KAID Health to combine PurpleLab’s large-scale structured claims data with KAID Health’s AI and natural language processing capabilities, creating an integrated view of patient journeys across structured and unstructured data. The acquisition is intended to expand PurpleLab’s AI-powered healthcare intelligence offerings and accelerate capabilities for coding accuracy, care management, clinical research, and value-based care initiatives.
SCH Capital Holdings, Inc. has acquired Boston-based Statera, a healthcare compensation management technology and consulting firm. Statera will be integrated into SCH's Clinician Nexus platform to expand physician compensation automation and analytics capabilities across health systems, academic medical centers, and clinician groups.
VaLogic Bio has acquired Air Systems Technologies (AST), a cleanroom certification and biosafety-testing specialist headquartered in Avon, Massachusetts. The acquisition expands VaLogic's service offerings for life sciences customers and strengthens its presence across the Mid-Atlantic and New England; AST will continue operating in Avon as VaLogic Bio.
Pyx Health has acquired FarmboxRx after receiving a $47.5 million investment from S2G Investments in strategic partnership with TT Capital Partners. The deal integrates FarmboxRx's customized food-box solutions into Pyx Health's mentor-driven care navigation platform to address food insecurity and strengthen member engagement for health plans, particularly in Medicare and Medicaid populations.
BioMarin Pharmaceutical Inc. completed its all-cash acquisition of Inozyme Pharma, Inc. for $4.00 per share, valuing the deal at approximately $270 million. The transaction adds INZ-701, a late-stage enzyme replacement therapy being developed for ENPP1 Deficiency, to BioMarin’s enzyme therapies portfolio.
bluebird bio entered into a definitive agreement to be acquired by funds managed by Carlyle and SK Capital Partners, with expected close in the first half of 2025. Under the deal, bluebird stockholders are set to receive $3.00 per share in cash plus a contingent value right (CVR) of up to $6.84 per share if a net sales milestone is achieved by 2027 (or an alternative $5.00 per share cash option later added).
Packaging Compliance Labs (PCL), a PE-backed provider of sterile packaging and testing services, has acquired Quest Engineering Solutions, an ISO 17025-accredited test lab based in Billerica, Massachusetts. The add-on expands PCL's East Coast footprint and broadens its testing capabilities for medical device and life sciences customers; PCL is backed by SV Health Investors.
GHR Healthcare has acquired Barton Healthcare Staffing, the nurse and allied health staffing affiliate of Barton Associates, Inc., with the transaction closing on May 3, 2025. The deal transfers Barton Healthcare Staffing’s nurse and allied clients and clinicians to GHR as Barton Associates refocuses on physician and advanced-practice locum tenens staffing.
2seventy bio entered into a definitive merger agreement to be acquired by Bristol Myers Squibb (BMS) for $5.00 per share in an all-cash transaction. The deal is expected to close in the second quarter of 2025, following a tender offer and a second-step merger.
Smile Doctors has acquired myOrthos, an orthodontic support organization with over 70 affiliated locations across 13 states, expanding Smile Doctors' network to more than 550 affiliated locations in 36 states and entering four new states. The acquisition is an add-on to Smile Doctors’ platform to increase provider density in key markets while ensuring continuity of care for myOrthos’ affiliated practices and patients.
Advanced Instruments, a wholly owned subsidiary of Patricia Industries, completed its acquisition of Nova Biomedical for an enterprise value of USD 2.2 billion. The transaction followed regulatory approval and resulted in the combined business operating under the Nova Biomedical name, led by Advanced Instruments’ CEO Byron Selman.
Azara Healthcare and i2i Population Health have joined forces to create an expanded population health and value-based care company serving safety-net providers. Global software investor Insight Partners led the merger and made a growth investment in the combined business, joining existing investor Hughes & Company; the new company will be headquartered in Burlington, Massachusetts with an office in Nashville, Tennessee.
Avel eCare has acquired Amwell Psychiatric Care (APC) from Amwell in an all-cash transaction worth approximately $21 million at closing plus an additional earn-out. The sale transfers APC technology, personnel and the affiliated Asana psychiatric clinical network to Avel as Amwell sharpens focus on its core digital care platform and strengthens its balance sheet. The acquisition expands Avel eCare's behavioral health capabilities and broadens its national telemedicine footprint.
HouseWorks Holdings, a PE-backed home care platform, has acquired two Massachusetts-based, founder-owned home care providers: O'Connell Care at Home (Holyoke/Springfield region) and Best Home Care (Wakefield). These add-on transactions expand HouseWorks' presence across Western Massachusetts and Greater Boston and represent the company's second and third acquisitions in the state since partnering with InTandem Capital in December 2022.
MDaudit, a Waltham, Massachusetts–based provider of billing, coding compliance and revenue integrity SaaS for healthcare providers, received a strategic growth investment from growth equity firm Bregal Sagemount, with existing investor Primus Capital also committing additional capital. Terms were not disclosed; the capital will be used to accelerate growth, new product development and expand MDaudit's market leadership in revenue cycle management.
SightMD acquired Papale Eye Center in 2025, marking SightMD’s first expansion into Massachusetts and adding a Springfield-based ophthalmology and laser eye surgery practice to its network. The Papale Eye Center will continue offering cataract, LASIK and other vision-correction services as part of the SightMD platform, expanding SightMD’s regional footprint and access to surgical capabilities.
Tarrytown Expocare Pharmacy, a national long-term care pharmacy focused on IDD and behavioral health, has acquired Greater Boston Long Term Care Pharmacy to establish a Massachusetts presence. The deal, supported by Sheridan Capital Partners and advised on the sell-side by M&A Healthcare Advisors, adds a regional location to Tarrytown's platform and aims to expand services to group homes and assisted living communities across the Commonwealth.
Zelis, a Boston-based healthcare technology company, sold a minority stake to a group of investors led by Mubadala Investment Company and including Norwest and HarbourVest, with Parthenon and Bain Capital remaining the majority owners. The transaction closed November 26, 2024 and brings strategic capital and investor support to fuel Zelis's continued growth in healthcare payments and financial technology.
IEH Laboratories & Consulting Group has acquired Founders Science Group (FSG), an analytical testing and formulation services lab based in Taunton, Massachusetts. The deal enabled one founder to retire while preserving the business operations and expands IEH's pharmaceutical and beauty-product testing capabilities within its global lab network.
NationsBenefits has acquired Good Measures, a Food-as-Medicine platform that combines clinical coaching, patented nutrition technology, and personalized food prescriptions. The acquisition integrates Good Measures' capabilities into NationsBenefits' supplemental benefits and fintech platform to expand medically-tailored nutrition offerings for health plans and their members across the United States.
Rural Healthcare Group (owned by private equity firm Kinderhook Industries) has acquired Steward Medical Group and Steward Health Care Network, consolidating the primary care clinics formerly part of Steward's hospital system into RHG’s platform. RHG will rebrand as Revere Medical, invest in clinic infrastructure and operations, and aim to preserve local primary care access across Massachusetts and nine other states.
Ascend Learning has acquired StaffGarden, a cloud-based clinical talent development and compliance platform trusted by over 800 hospitals, to expand its healthcare workforce development capabilities. The acquisition will integrate StaffGarden's digital clinical ladder and competency-management tools into Ascend Learning's portfolio to help health systems address retention and professional development challenges.
ProductLife Group (PLG), a global life‑sciences consulting and outsourcing firm, has acquired Halloran Consulting Group, a U.S.-based life sciences consulting firm with offices in Boston and San Diego. The acquisition expands PLG’s regulatory, quality, clinical, and organizational capabilities while strengthening its presence in the North American market to better support pharmaceutical, biotech, and medical device clients.
Lawrence General Hospital, together with a newly formed not-for-profit, acquired the assets and operations of Holy Family Hospital's Methuen and Haverhill campuses from Steward Health Care System. The Bankruptcy Court‑approved transaction closed on October 1, 2024 for $28 million and transferred more than 1,300 employees to the new ownership as part of creating a regional health care system in the Merrimack Valley.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
Recent Massachusetts transactions include healthcare enrollment and care coordination platforms (e.g., Azara Healthcare / Advocatia) and regional medical transportation capacity expansion (Coastal Medical Transportation Systems (CMTS) / Alert Ambulance Service).
They include a mix. Alongside services-oriented transactions, the page also reflects diagnostics and development services activity such as CareDx acquiring Naveris and Veristat acquiring Certara’s Regulatory and Medical Writing business.
The transactions described are located in Massachusetts, United States, with the page consistently tied to Massachusetts activity.
The page lists recurring buyer names including The Stepping Stones Group, Five Arrows Capital Partners, Health Enterprise Partners, Emmes, Behrman Capital, Gemini Therapeutics, Inc., Access Biotechnology, and OrbiMed.